Heart drug safety checked in japanese kids
NCT ID NCT06149104
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study looked at the safety of the drug sacubitril/valsartan in Japanese children with heart failure. Eight children who had already finished a previous study took part. The goal was to collect more safety information and give them access to the drug until a child-friendly version becomes available in Japan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Ōbu, Aichi-ken, 474 8710, Japan
-
Novartis Investigative Site
Ōmura, Nagasaki, 856-8562, Japan
-
Novartis Investigative Site
Bunkyo Ku, Tokyo, 113 8655, Japan
-
Novartis Investigative Site
Setagaya-ku, Tokyo, 157-8535, Japan
-
Novartis Investigative Site
Saitama, 330 8777, Japan
-
Novartis Investigative Site
Toyama, 930-0194, Japan
Conditions
Explore the condition pages connected to this study.